Diagnostic accuracy of alzheimer’s disease: A neuropathological study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta Neuropathologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004010050412PMID 8787153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease

  1995cited by this paper
• Interlaboratory comparison of neuropathology assessment in Alzheimer's disease.

  1995cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1995cited by this paper
• Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

  1995cited by this paper
• beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.

  1994cited by this paper
• Reliability of NINDS‐AIREN clinical criteria for the diagnosis of vascular dementia

  1994cited by this paper
• How does cerebrovascular disease cause dementia?

  1994cited by this paper
• Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

  1994cited by this paper
• Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.

  1994cited by this paper
• Vascular dementia

  1993cited by this paper
• Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

  1993cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• A quantitative MRI study of vascular dementia

  1992cited by this paper
• Cranial Computed Tomographic Observations in Multi‐Infarct Dementia: A Controlled Study

  1992cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Very mild Alzheimer's disease

  1991cited by this paper
• Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE.

  1990cited by this paper
• Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings.

  1990cited by this paper
• Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person

  1990cited by this paper
• Accuracy of clinical diagnosis of Alzheimer's disease.

  1990cited by this paper
• Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

  1990cited by this paper
• Clinicopathological analysis of dementia disorders in the elderly.

  1990cited by this paper
• Neuropathological diagnosis of Alzheimer disease.

  1989cited by this paper
• Lewy Bodies in Alzheimer Disease‐One or Two Diseases?

  1989cited by this paper
• Intellectual impairment and cerebral lesions in multiple cerebral infarcts. A clinical-computed tomography study.

  1988cited by this paper
• Vascular dementia is underdiagnosed.

  1988cited by this paper
• The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease

  1988cited by this paper
• Aetiological considerations and risk factors for multi-infarct dementia.

  1988cited by this paper
• Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.

  1988cited by this paper
• Clinico‐pathologic studies in dementia

  1988cited by this paper
• Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

  1988cited by this paper
• NEUROPATHOLOGICAL DEFINITION OF ALZHEIMER DISEASE: MULTIVARIATE ANALYSES IN THE MORPHOMETRIC DISTINCTION BETWEEN ALZHEIMER DEMENTIA AND NORMAL AGING

  1988cited by this paper
• Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases

  1988cited by this paper
• Validation of clinical diagnostic criteria for Alzheimer's disease

  1988cited by this paper
• Cortical biopsy results in Alzheimer's disease

  1987cited by this paper
• The clinical diagnosis of Alzheimer's disease.

  1987cited by this paper
• Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).

  1987cited by this paper
• Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles

  1987cited by this paper
• Alzheimer's disease: neuropathological correlates of cognitive and motor disorders

  1987cited by this paper
• Meningio‐angiomatosis: A Report of Six Cases with Special Reference to the Occurrence of Neurofibrillary Tangles

  1986cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

  1985cited by this paper
• Validity of clinical diagnosis in dementia: a prospective clinicopathological study.

  1985cited by this paper
• ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGES

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings.

  1983cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• ARE BOTH PLAQUES AND TANGLES REQUIRED TO MAKE IT ALZHEIMERʼS DISEASE?: 70

  1982cited by this paper
• Plaques, tangles and dementia. A quantitative study.

  1982cited by this paper
• Plaques, tangles and Alzheimer's disease

  1982cited by this paper
• Pathological verification of ischemic score in differentiation of dementias

  1980cited by this paper
• Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia

  1979cited by this paper
• Senile Degenerative Brain Lesions and Dementia

  1975cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper
• Critical analysis of the disability in Parkinson's disease.

  1968cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorder

  2025cites this paper
• Effect of dorsolateral prefrontal cortex structural measures on neuroplasticity and response to paired-associative stimulation in Alzheimer’s dementia

  2024cites this paper
• Beta-to-Theta Entropy Ratio of EEG in Aging, Frontotemporal Dementia, and Alzheimer's Dementia.

  2024cites this paper
• Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia

  2023cites this paper
• Small molecular fluorescent probes for Alzheimer's disease associated active species.

  2023cites this paper
• Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data

  2019cites this paper
• Analyse de la morphologie des sillons corticaux et de l'activation microgliale dans la maladie d'Alzheimer : étude couplée en IRM, TEP-PiB et TEP-DPA

  2018cites this paper
• Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies

  2018cites this paper
• Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

  2017cites this paper
• “Where is Dementia?” A Systematic Literature Review Exploring Neuroanatomical Aspects of Dementia

  2017cites this paper
• A new potential biomarker for dementia with Lewy bodies

  2017cites this paper
• EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study

  2016cites this paper
• Amyloid-β and chronic cerebral hypoperfusion in the early pathogenesis of Alzheimer’s disease

  2016cites this paper
• Machine Learning Approach to Improve Prediction Accuracy of Alzheimer’s Disease

  2016cites this paper
• The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update

  2015cites this paper
• The impact of homocysteine and B vitamins on Alzheimer’s disease, cognitive performance and structural brain changes

  2013cites this paper
• Alzheimer’s Disease and Diabetes

  2013cites this paper
• Exploring the role of vitamin E in Alzheimer’s disease : an epidemiological and clinical perspective

  2012cites this paper
• Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

  2012cites this paper
• Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

  2012cites this paper
• Evolution of the diagnostic criteria for degenerative and cognitive disorders.

  2011cites this paper
• Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

  2011cites this paper
• How to Distinguish Dementia with Lewy Bodies from Alzheimer Disease

  2010cites this paper
• Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease

  2010cites this paper
• Kapitel 8 – Organische (und symptomatische) psychische Störungen

  2009cites this paper
• Comorbidity in Dementia

  2009cites this paper
• NMR Metabolomics Techniques and Mathematical Tools as an Aid in Neurological Diagnosis

  2009cites this paper
• Cholesterol and late-life cognition. An epidemiological and clinical approach

  2009cites this paper
• Biological fluid biomarkers in neurodegenerative parkinsonism

  2009cites this paper
• Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

  2009cites this paper
• Evaluation of different stages of dementia employing neuropsychological and machine learning techniques

  2009cites this paper
• Balance Features in Alzheimer's Disease and Amnestic Mild Cognitive Impairment

  2009cites this paper
• Diagnostic accuracy of Alzheimer’s disease: A clinicopathological study

  2009influential citation
• Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders

  2009cites this paper
• Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests

  2009cites this paper
• Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia

  2008cites this paper
• Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial.

  2008cites this paper
• Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

  2008cites this paper
• Biological CSF markers of Alzheimer's disease.

  2008cites this paper
• The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.

  2008cites this paper
• EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.

  2008cites this paper
• Study of Cerebrospinal Fluid Tissue Transglutaminase , T-TAU , Amyloid Β 42 in Alzheimer ’ s Disease

  2008cites this paper
• Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.

  2008cites this paper
• Long-Term Treatment Response, Predictors and Biochemical Markers in Alzheimer's Disease

  2008cites this paper
• Fluoro-2-Deoxy-D-Glucose (FDG)-PET in APOEε4 Carriers in the Australian Population

  2008cites this paper
• Glutamate-glutamine cycling in Alzheimer's disease.

  2007cites this paper
• Demenz und Depression bei Patienten mit idiopathischem Parkinson-Syndrom

  2007influential citation
• White matter mapping in Alzheimer's disease: A neuropathological study.

  2006cites this paper
• CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

  2006cites this paper
• Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

  2006cites this paper
• CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.

  2005cites this paper
• CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment

  2005cites this paper
• Recent Clinical-Pathologic Research on the Causes of Dementia in Late Life: Update From the Honolulu-Asia Aging Study

  2005cites this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cites this paper
• Comorbidity in dementia: an autopsy study.

  2004cites this paper
• Post mortem sampling of the brain and other tissues in neurodegenerative disease

  2004cites this paper
• [18F]FDG-PET in Patients with Alzheimer’s Disease: Marker of Disease Spread

  2004cites this paper
• Alzheimer's disease: one disorder, too many genes?

  2004cites this paper
• Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease.

  2004cites this paper
• CSF biomarkers for mild cognitive impairment

  2004cites this paper
• Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

  2004cites this paper
• Core biological marker candidates of Alzheimer’s disease – perspectives for diagnosis, prediction of outcome and reflection of biological activity

  2004cites this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cites this paper
• CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry.

  2003cites this paper
• Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease

  2003cites this paper
• Biochemical and molecular studies using human autopsy brain tissue

  2003cites this paper
• Diagnostic challenges of using CSF assay of tau and beta-amyloid(42) in atypical degenerative dementias of the Alzheimer type.

  2003cites this paper
• CSF-tau, CSF-Aß1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer’s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity

  2003cites this paper
• The Validity and Reliability of 6 Sets of Clinical Criteria to Classify Alzheimer’s Disease and Vascular Dementia in Cases Confirmed Post-Mortem: Added Value of a Decision Tree Approach

  2003cites this paper
• CSF markers for incipient Alzheimer's disease.

  2003cites this paper
• Treating the full spectrum of dementia with memantine

  2003cites this paper
• Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.

  2003cites this paper
• Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.

  2003cites this paper
• Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis.

  2002cites this paper
• Inherited dementias.

  2002cites this paper
• Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

  2002cites this paper
• Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease.

  2002cites this paper
• Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

  2001cites this paper
• α‐Synuclein pathology is highly dependent on the case selection

  2001cites this paper
• Potential genetic markers of sporadic Alzheimer's dementia

  2001cites this paper
• Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

  2001cites this paper
• CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease

  2001cites this paper
• Accuracy of clinical criteria for AD in the Honolulu–Asia Aging Study, a population-based study

  2001cites this paper
• One-Carbon Metabolism and Other Biochemical Correlates of Cognitive Impairment as Visualized by Principal Component Analysis

  2001cites this paper
• Local and systemic GM‐CSF increase in Alzheimer's disease and vascular dementia

  2001cites this paper
• Alzheimer's disease: its diagnosis and pathogenesis.

  2001cites this paper
• CSF levels of tau, β-amyloid1–42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

  2000cites this paper
• Diagnosing Dementia: Interrater Reliability Assessment and Accuracy of the NINCDS/ADRDA Criteria versus CERAD Histopathological Criteria for Alzheimer’s Disease

  2000cites this paper
• Aging, mild cognitive impairment, and Alzheimer's disease.

  2000cites this paper
• [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].

  2000cites this paper
• Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry

  2000cites this paper
• Neuropathologic Substrates of Ischemic Vascular Dementia

  2000cites this paper
• Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall.

  2000cites this paper
• Diagnostic accuracy of dementia with Lewy bodies.

  2000cites this paper
• Frontotemporal Dementia Can Be Distinguished from Alzheimer’s Disease and Subcortical White Matter Dementia by an Anterior-to-Posterior rCBF-SPET Ratio

  2000cites this paper
• Prevention of vascular dementia.

  1999cites this paper
• Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia

  1999cites this paper
• Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden

  1999cites this paper
• Overlap between pathology of Alzheimer disease and vascular dementia.

  1999cites this paper
• The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample.

  1999cites this paper